All diabetic patients should be treated with GLP1 and/or GIP agonists.

29 August 2022 (08:48 - 09:06)
Organised by:
Congress Presentation Part of: Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by